Manufacturers Life Insurance Company, The Verve Therapeutics, Inc. Transaction History

Manufacturers Life Insurance Company, The

$109 Billion
Q4 2024

A detailed history of Manufacturers Life Insurance Company, The transactions in Verve Therapeutics, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 26,638 shares of VERV stock, worth $193,924. This represents 0.0% of its overall portfolio holdings.

Number of Shares

26,638

Previous 27,294 2.4%

Holding current value

$193,924

Previous $132,000 13.64%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$4.5 - $7.19 $2,952 - $4,716	-656 Reduced 2.4%	26,638 $150,000
Q3 2024 Nov 13, 2024	SELL	$4.4 - $7.86 $3,568 - $6,374	-811 Reduced 2.89%	27,294 $132,000
Q2 2024 Aug 14, 2024	BUY	$4.76 - $12.79 $22,652 - $60,867	4,759 Added 20.38%	28,105 $137,000
Q1 2024 May 14, 2024	SELL	$10.81 - $17.96 $25,176 - $41,828	-2,329 Reduced 9.07%	23,346 $310,000
Q4 2023 Feb 13, 2024	BUY	$8.84 - $18.7 $7,275 - $15,390	823 Added 3.31%	25,675 $357,000
Q3 2023 Nov 15, 2023	BUY	$11.42 - $20.82 $46,970 - $85,632	4,113 Added 19.83%	24,852 $329,000
Q2 2023 Aug 11, 2023	BUY	$13.34 - $19.9 $24,425 - $36,436	1,831 Added 9.68%	20,739 $388,000
Q1 2023 May 15, 2023	SELL	$14.3 - $24.01 $1,043 - $1,752	-73 Reduced 0.39%	18,835 $271,000
Q4 2022 Aug 11, 2023	BUY	$17.85 - $40.7 $66,419 - $151,444	3,721 Added 24.5%	18,908 $365,000
Q4 2022 Feb 13, 2023	BUY	$17.85 - $40.7 $66,419 - $151,444	3,721 Added 24.5%	18,908 $365,000
Q3 2022 Aug 11, 2023	SELL	$15.63 - $41.49 $3,985 - $10,579	-255 Reduced 1.65%	15,187 $521,000
Q3 2022 Nov 03, 2022	SELL	$15.63 - $41.49 $3,985 - $10,579	-255 Reduced 1.65%	15,187 $522,000
Q2 2022 Aug 11, 2023	BUY	$11.14 - $23.17 $6,438 - $13,392	578 Added 3.89%	15,442 $235,000
Q2 2022 Aug 15, 2022	BUY	$11.14 - $23.17 $6,438 - $13,392	578 Added 3.89%	15,442 $236,000
Q1 2022 Aug 11, 2023	SELL	$20.92 - $39.36 $83,073 - $156,298	-3,971 Reduced 21.08%	14,864 $339,000
Q1 2022 May 20, 2022	BUY	$20.92 - $39.36 $124,704 - $234,624	5,961 Added 66.95%	14,864 $339,000
Q4 2021 Feb 16, 2022	BUY	$31.94 - $54.82 $15,139 - $25,984	474 Added 5.62%	8,903 $328,000
Q3 2021 Nov 12, 2021	BUY	$46.0 - $73.99 $387,734 - $623,661	8,429 New	8,429 $396,000

Others Institutions Holding VERV

# of Institutions

180

Shares Held

76.4M

Call Options Held

70.3K

Put Options Held

194K

View Full List

About Verve Therapeutics, Inc.

Ticker VERV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,942,300
Market Cap $436M
Description
Verve Therapeutics, Inc., a genetic medicines company, engages in developing gene editing medicines for patients to treat cardiovascular diseases. Its lead product candidate is VERVE-101, a single-course gene editing treatment that permanently turns off the PCSK9 gene in the liver. The company also engages in the development of ANGPTL3 program t...

More about VERV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.

Account

Manufacturers Life Insurance Company, The Verve Therapeutics, Inc. Transaction History